Medicon Valley Alliance is continually adding new life science companies and organisations as members.
These companies and organisations have decided to join forces and strengthen their ties within the region, thereby anhancing their visibility with national and international companies looking at life science in Medicon Valley.
Below is a list of the companies that have most recently joined the Medicon Valley Alliance!
Take a look and see if one of them is your new business partner. If you wish to view a directory of all companies and organisations in Medicon Valley – click here!
Unseen Bio
Medicoindustrien
Labconnect
Global Partner of Choice
LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations, backed by 20+ years of experience and 2,000+ clinical studies across 93 countries.
With modern operations and strategic alliances with world-leading laboratories, LabConnect is uniquely positioned to provide access to the latest innovation and automation.
Arithmos
Mission
As trusted consultants in the pharmaceutical sector, our mission is to drive digital transformation and implement value-added services that foster innovation. By leveraging advanced technologies and strategies, we help streamline processes, enhance decision-making, and accelerate the development of novel therapeutics, all while caring for and preserving our planet.
Vision
To be the one partner life science innovators rely on for their challenges — uniting knowledge, technology, and operations to drive every step from molecule to market and beyond.
What we offer
Headquartered in Italy and with offices in the UK, we provide reliable solutions and services in full compliance with regulatory and quality standards to our customers across the EU and worldwide.
Life Science companies rely on us to enhance the value of technology solutions and efficiently support critical processes such as R&D operations, clinical development, quality assurance, and pharmacovigilance.
Our extensive experience in handling complex projects and delivering end-to-end services drives our unwavering commitment to continually improve and meet the exacting demands of the Life Sciences industry.
We support our customers in achieving high-value business performance through the most appropriate solutions, digital projects, and consultancy and services.
Beckhoff Automation AB
Beckhoff implements open automation systems using proven PC-based control technology. The main areas that the product range covers are industrial PCs, I/O and fieldbus components, drive technology, automation software, control cabinet-free automation, and hardware for machine vision. Product ranges that can be used as separate components or integrated into a complete and mutually compatible control system are available for all sectors. Our New Automation Technology stands for universal and industry-independent control and automation solutions that are used worldwide in a large variety of different applications, ranging from CNC-controlled machine tools to intelligent building control.
Clinigen
Clinigen is a global pharmaceutical services company trusted by over 1,000 pharma and biotech partners. With more than 35 years of experience, we accelerate access to critical medicines at every stage of the product lifecycle. As pathfinders, our team of over 1,100 specialists expertly navigate the complexities of clinical trial supply, early access programs, regulatory services, and long-term commercialisation through both licensed and unlicensed pathways. Operating across five continents, we deliver innovative solutions to over 130 countries each year. Whatever the challenge, we find a way.
InSilico Consulting
InSilico Consulting is a bioinformatics and data science consultancy and contract research organization (CRO) based in Lund, Sweden. With over a decade of combined industry and academic experience we provide expert hands-on support and advice to our clients, specializing in genomics and other omics modalities, clinical bioinformatics, oncology, and precision medicine.
Veranex
The Integrated, Patient-Centric Innovation CRO
Traditional CROs and boutique vendors fragment device and diagnostic development with multiple hand-offs, blind spots, and learning curves thereby increasing the likelihood for costly delays and missed goals.
Veranex unites product design, engineering, manufacturing, preclinical, clinical, regulatory, quality and market-access expertise under one Innovation CRO (iCRO) roof. Every decision is informed and connected with cross-disciplinary experts. The result: proven speed and delivery, crystal-clear accountability, innovative next-generation devices and diagnostics that produce life-changing patient benefits at a global scale.
CRISPR Medicine News
CRISPR Medicine News (CMN) has been chronicling the rapid rise of gene editing since 2018, following CRISPR’s transformation from a revolutionary tool to a real-world therapy – culminating in the first-ever approved CRISPR-based treatment in 2023.
We provide in-depth, expert-written coverage across gene-editing technologies, delivery systems, in vivo applications, pre-clinical and clinical developments, and safety innovations. Our reporting is driven by scientific rigor and reviewed by the experts we interview.
Subscribers stay current through our CMN Weekly Newsletter, regular CMN Briefs, CMN Special and CMN Interviews that feature the most recent and interesting research, frequent CMN Clinical Trial Updates, and a continually updated CRISPR Medicine Clinical Trials register. Our CMN Webinars and CMN Live interviews further ensure that readers at every level can access critical insights.
In 2021 we launched WeDoCRISPR (WDC) – the world’s first CRISPR-focused community for students and early-career scientists. Through engaging explainers, videos, and visuals, WDC makes CRISPR accessible and exciting for the next generation of genome editors. WDC is managed by Martina Franchini, PhD., Antonio Carusillo, PhD., and Manel Llado Santaeularia, PhD.
Each year, our efforts culminate in the CRISPR Medicine Conference (CRISPRMED) in Copenhagen, where global leaders in CRISPR/genomic medicine connect, collaborate, and chart the path forward.
GenScript ProBio – A Global CDMO
GenScript ProBio – Biologics CDMO
GenScript ProBio, a subsidiary of GenScript Biotech Corporation, offers end-to-end CDMO services from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in CGT, vaccine, antibody and recombinant protein drug, aiming to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 60 IND approvals since October 2017.
GenScript ProBio’s total CGT solution covers CMC of plasmid, virus, mRNA vaccine and nucleic acid drugs for IND filing as well as clinical manufacturing and commercial manufacturing. GenScript ProBio’s innovative solutions for biologics discovery and development include therapeutic antibody discovery, antibody engineering and antibody characterization. In the biologics CDMO service, GenScript ProBio has built a DNA to GMP material platform, including stable cell line development, host cell commercial license, process development, analytical development to clinical and commercial manufacturing, and offer fed-batch and perfusion processes to meet the growing needs for antibody and protein drugs. GenScript ProBio has established GMP capacity that meets regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA).
Visit our website to learn more.